メインコンテンツに移動
  • 認定パートナー
  • ELGAについて
    • ELGAについて
    • 採用情報
    • イベント
  • サポート
    • ラボのプランニング
    • 製品を登録
    • Register Your Product (USA & Canada Only)
  • お問い合わせ
  • U.S.A.
  • U.K.
  • Deutschland
  • España
  • France
  • Italia
  • Brasil
  • 中国
ホーム ELGA LabWater
  • 製品
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • ELGA全製品ライン
  • 用途
    • ガスクロマトグラフィー
    • ラボ用水の一般要件
    • 免疫組織染色
    • 分光測光法
    • 原子分光学
    • 微生物学的分析
    • 液体クロマトグラフィー
    • 臨床生化学
    • 質量分析
    • 遺伝学
    • 電気化学
  • 純水製造技術
    • PureSure
    • ろ過
    • イオン交換
    • 活性炭
    • 紫外線
    • 逆浸透(RO)
    • 電気脱イオン処理(EDI)
  • 水中の不純物
    • 微生物&細菌
    • 有機化合物
    • 溶存ガス
    • 無機化合物
    • 粒子状物質
  • Knowledge
    • ブログ
    • ケーススタディ
    • 超純水
    • ガイド&ホワイトペーパー
  • 製品
    • PURELAB
    • CENTRA
    • MEDICA
      • Hubgrade
      • MEDICA BIOX
    • BIOPURE
    • ELGA全製品ライン
      • PURELAB® Classic
  • 用途
    • ガスクロマトグラフィー
    • ラボ用水の一般要件
    • 免疫組織染色
    • 分光測光法
    • 原子分光学
    • 微生物学的分析
    • 液体クロマトグラフィー
      • Hochleistungsflüssigkeitschromatographie (HPLC)
    • 臨床生化学
    • 質量分析
    • 遺伝学
    • 電気化学
  • 純水製造技術
    • PureSure
    • ろ過
    • イオン交換
    • 活性炭
    • 紫外線
    • 逆浸透(RO)
    • 電気脱イオン処理(EDI)
  • 水中の不純物
    • 微生物&細菌
    • 有機化合物
    • 溶存ガス
    • 無機化合物
    • 粒子状物質
  • Knowledge
    • ブログ
      • Analytical Chemistry
      • Clinical & Pharma
      • Cool Science
      • Environment and sustainability
      • Life in the lab
      • Purelab product design
      • Science of the future
      • Water Purity
      • Water in the lab
    • ケーススタディ
      • 南アジアのAbbott Diagnostics、ELGA MEDICAシステムを選択
      • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
      • Argenta chooses DKSH New Zealand to deliver Ultrapure water in Animal Pharma
      • Clean Water for a Clean Future
      • LS Scientific & ELGA deliver UltraPure water to the NAFDAC Laboratory
      • Lifebrain Group chooses ELGA as water partner for new modern 24/7 PCR-COVID-19 laboratory in Vienna, Austria.
      • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
      • DASA:ブラジル最大の医療診断企業
      • 免疫血清学ラボの稼働時間最大化を支援するELGA
      • Fondazione Telethon Continues to Choose ELGA Labwater as a Trusted Partner
      • ジェネリック医薬品開発における超純水(I型水+)の重要性
      • Siemens ADVIA分析装置用に市立総合病院がMEDICA®Proを導入
      • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
      • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
      • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
      • PURELAB® flex:現代的な研究手法における理想的なトレーニングシステム
      • Powering Cutting-Edge Gene Research
      • Sichere Reinstwasserversorgung für präzise Produkttests
      • Zentrale Reinstwasser-Aufbereitung für Analyser
      • ELGA LabWater and Beckman Coulter Join Forces
      • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
      • 超純水により南極の謎を解明
      • Advancing Genetic Technologies
      • Cross Infection Control: Pure and Simple
      • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
    • 超純水
    • ガイド&ホワイトペーパー
      • HPLC用水の純度
      • 製薬におけるHPLC
      • 臨床でのリスクの低減
      • サステナビリティ
  • U.S.A.
  • U.K.
  • Deutschland
  • España
  • France
  • Italia
  • Brasil
  • 中国
  • プライバシーポリシー
  • 利用規約
  • 世界的な法令順守
  • 特許
  • サイト管理者情報
  • ホーム
  • Improving the Routine Analysis of Antipsychotic Drugs
Clinical & Pharma
Analytical Chemistry

Improving the Routine Analysis of Antipsychotic Drugs

20 9月 2021
- by Dr Alison Halliday

Mind drugs

Researchers validate a new LC-MS/MS method for quantifying 38 antipsychotics and metabolites in plasma for therapeutic drug monitoring and forensic applications.

Antipsychotic medications have revolutionised the treatment of psychiatric disorders. These substances fall into two main classes – first-generation antipsychotics (FGAs), which were developed in the late 1950s for the treatment of psychosis symptoms. In recent decades, these have largely been replaced by second-generation antipsychotics (SGAs) – or ‘atypicals’.

The shift towards SGAs has partly been driven by the lower risk of developing severe movement problems than FGAs. However, atypicals may be more likely to cause other potentially serious side effects, including weight gain, heart problems and diabetes.

The number of patients being prescribed antipsychotics is growing worldwide, despite these safety concerns. The increasing off–label use of SGAs mainly consists of the treatment of anxiety and insomnia disorders in adults and ADHD in children.

Clinical and Forensic Analysis

The risk of undesired side effects from antipsychotics, combined with the increased use in children, drives a need for strict therapeutic drug monitoring. From a forensics perspective, more daytime traffic accidents are caused by psychotropic medication (combined with alcohol) than illicit drugs.

But many of the current methods used for clinical and forensic purposes are limited – such as analysing only a small number of antipsychotics or involving long, complex protocols.

In a new study, published in the Journal of Chromatography B, researchers develop a multi-analyte liquid chromatography triple quadrupole mass spectrometry method for the quantification of 38 antipsychotic drugs in plasma.1

A Fully Validated Method

The researchers extracted samples by a straightforward liquid-liquid extraction with methyl–tertiary–butyl–ether and the compounds of interest were chromatographically separated within six minutes. They showed that the calibration curves covered the recommended therapeutic range for all compounds, in addition to levels above and below for most substances.

After successfully validating the method according to relevant European Medicines Agency (EMA) guidelines, the team applied their new method to the analysis of samples from 137 medico-legal cases. They found 46 samples that were positive for one or more antipsychotic drugs, with their results confirming the relatively common use of the SGAs quetiapine and olanzapine, as well as the continued presence of the FGA haloperidol in Europe.

The researchers used ultrapure water produced in–house from an ELGA PURELAB® laboratory water purification system, minimising the risk of adding trace contaminants that may affect their results.

Application to Routine Analysis

In this study, researchers create a new fully validated, time-efficient quantitative multi-analyte method for therapeutic drug monitoring and forensic analysis of a wide range of antipsychotic medications in plasma.

The sample preparation and chromatographic settings were previously successfully applied in the quantification of other psychoactive drug classes (antidepressants and benzodiazepines), allowing for easy transitioning or merging of methods.

The method was further applied to more than 100 medico-legal cases and its performance was thoroughly evaluated through proficiency testing schemes.

Why Choose ELGA LabWater?

ELGA LabWater has been a trusted name in pure and ultrapure water since 1937. Our dedication to ultrapure and pure water is a guarantee that we will continue to provide the best solutions with the best service.

Reference:

  1. Degreef, M. et al. Multi–analyte LC-MS/MS quantification of 38 antipsychotics and metabolites in plasma: Method validation & application to routine analyses. J Chromatog B 2021;1179:122867 doi: https://doi.org/10.1016/j.jchromb.2021.122867

Dr Alison Halliday

After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

HPLC Pharma

Optimise your HPLC to avoid water contamination
when manufacturing life-saving drugs.

Understand the role of HPLC and different levels of water purity in drug manufacture, analysis and pharmaceutical quality assurance

              Click Here 

 

  • Enquiry
  • 見積もりを取得
  • デモを予約する
  • 承認されたパートナーを見つける

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

見積もりを取得

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

デモを予約する

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater US Head Quarters

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
電話: +44 (0) 203 567 7300
ファックス:+44 (0) 203 567 7205

ELGA LabWater本社

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
電話: +44 (0) 203 567 7300
ファックス:+44 (0) 203 567 7205

ケーススタディ

  • Abbott Diagnostics(アボットダイアグノスティクス)
  • DASA Medical Diagnostics(DASA医療診断)
  • NeoDIN Medical Institute(NeoDIN医療機関)
  • UHNS(University Hospital of North Staffordshire NHS Trust/北スタンフォードシャア大学病院)
  • Olsberg Vocational College(オルスバーグ専門学校)

リソース

  • 超純水について
  • ガイド&ホワイトペーパー
  • 純水製造技術
  • 用途
  • 水中の不純物

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • 言語
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • 他のVeoliaサイト
    • Veolia
    • Veolia Fondation
    • Veolia Water Technologies

©VWS(UK)Ltd.はELGA LabWaterとして取引されています。2022-全著作権所有。
ELGAはVeoliaのグローバルなラボ用水のブランド名です。

  • プライバシーポリシー
  • 利用規約
  • 世界的な法令順守
  • 特許
  • サイト管理者情報
Elga Veolia
TOP

© 2017 ELGA Veolia